Medication reliability of epileptic children treated with phenytoin
Wässer, S.; Walther, H.; Jalinski, W.; Scheidemann, I.; Bergmann, L.
Zeitschrift für Arztliche Fortbildung 74(23): 1106-1110
1980
ISSN/ISBN: 0044-2178 PMID: 7210725 Document Number: 166822
Document emailed within 1 workday
Related Documents
Galas-Zgorzalewicz, B.; Borysewicz-Lewicka, M.; Zgorzalewicz, M.; Borowicz-Andrzejewska, E. 1996: The effect of chronic carbamazepine, valproic acid and phenytoin medication on the periodontal condition of epileptic children and adolescents Functional Neurology 11(4): 187-193Liamsuwan, S.; Jaiweerawattana, U. 2011: Correlation between serum and salivary phenytoin concentrations in Thai epileptic children Journal of the Medical Association of Thailand 94(Suppl 3): S172-S177
Wässer, S.; Jalinski, W.; Quednow, B.; Walther, H. 1984: Initial therapeutic results in epileptic children with and without serum-controlled phenytoin treatment Padiatrie und Grenzgebiete 23(1): 11-14
Miles, M.V.; Snead, O.C.; Thorn, M.D. 1988: Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin Clinical Pharmacy 7(9): 688-693
Ahuja, S.R.; Karande, S.; Kulkarni, M.V. 2000: Cerebellar atrophy in an epileptic child: is it due to phenytoin? Journal of Postgraduate Medicine 46(4): 278-279
Devilat, M.; Germaín, L.; Valenzuela, B. 1983: Predictive factors of recurrences in children with epileptic crises treated for 5 years Revista Chilena de Pediatria 54(6): 396-401
Szkilnik, R.; Brus, R. 1988: Phenytoin: a new look at its anti-epileptic mechanism and adverse effects Neurologia i Neurochirurgia Polska 22(3): 246-251
Gatti, G.; Perucca, E.; Caravaggi, M.; Poloni, M.; Frigo, G.M.; Crema, A. 1977: Pharmacokinetics of phenytoin following intravenous administration in epileptic patients Il Farmaco; Edizione Pratica 32(9): 470-474
Sandyk, R. 1981: Choreo-athetosis induced by phenytoin in an epileptic child. A case report South African Medical Journal 60(16): 627-628
Dahllöf, G.; Axiö, E.; Modéer, T. 1991: Regression of phenytoin-induced gingival overgrowth after withdrawal of medication Swedish Dental Journal 15(3): 139-143
Sirisamut, T.; Chinvarun, Y.; Tantisira, M.H. 2014: Effects of phenytoin and valproic acid on cognitive functions of Thai epileptic patients: a pilot study Journal of the Medical Association of Thailand 97(Suppl 2): S77-S87
Treesirichod, A.; Chaithirayanon, S.; Chansakulporn, S. 2015: Self-Medication for Dermatologic Diseases among Children Treated at the HRH Princess Maha Chakri Sirindhorn Medical Center Journal of the Medical Association of Thailand 98(Suppl 9): S135-S139
Nelson, W.J.; Edwards, S.A.; Roberts, A.W.; Keller, R.J. 1978: Comprehensive self-medication program for epileptic patients American Journal of Hospital Pharmacy 35(7): 798-801
Kariks, J.; Perry, S.W.; Wood, D. 1971: Serum folic acid and phenytoin levels in permanently hospitalized epileptic patients receiving anticonvulsant drug therapy Medical Journal of Australia 2(7): 368-371
Otoom, S.; Bakhiet, M.; Khan, A.; Sequeira, R. 2006: Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders Neuro Endocrinology Letters 27(1-2): 85-88
Hallas, J. 2006: Reliability of medication errors Ugeskrift for Laeger 168(13): 1305
Saylor, K.E.; Buermeyer, C.M.; Spencer, T.J.; Barkley, R.A. 2002: Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication Journal of Clinical Psychiatry 63(Suppl 12): 23-28
Jefferys, R.J. 2005: Lower phenytoin serum levels in persons switched from brand to generic phenytoin Neurology 65(4): 657-8; Author Reply 657-8
Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582
Hernández, R.; Fernández, M.d.l.A.; Miranda, G.; Suástegui, R. 2005: Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 57(4): 522-531